Phosphonic acid derivates and their use as P2Y12 receptor antagonists

Details for Australian Patent Application No. 2008331163 (hide)

Owner ACTELION PHARMACEUTICALS LTD

Inventors Caroff, Eva; Hubler, Francis; Meyer, Emmanuel; Hilpert, Kurt; Renneberg, Dorte

Agent A J Park

Pub. Number AU-A-2008331163

PCT Pub. Number WO2009/069100

Priority PCT/ IB2007/054850 29.11.07 IB

Filing date 28 November 2008

Wipo publication date 4 June 2009

International Classifications

C07F 9/6558 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61K 31/665 (2006.01) - having oxygen as a ring hetero atom, e.g. fosfomycin

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07F 9/6571 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6584 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/069100 Priority application(s): WO2009/069100

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331166-Process for the preparation of substituted 1,3-oxathiolanes

2008331158-Antiviral nucleoside compounds